Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834166 | 0.99 | CYP2C9 (0.42) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25903121 | 0.88 | ADORA3 (0.38) | CYP2C9SMN1; SMN2NPSR1NPC1POLB | |
| SCHEMBL25903119 | 0.87 | LMNA (0.44) | MEN1KMT2ASMN1; SMN2NPSR1POLB | |
| SCHEMBL4580279 | 0.84 | AKR1C1 (0.46) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL27593585 | 0.81 | LMNA (0.48) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL4580283 | 0.80 | AKR1C1 (0.42) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25468053 | 0.80 | ELANE (0.42) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29319752 | 0.79 | MAOB (0.40) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25468056 | 0.79 | CYP2C9 (0.39) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14713746 | 0.78 | CYP2C9 (0.39) | CYP2C9MEN1CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | CYP2C9 1002/4885MEN1 1250/4885CYP1A2 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.